Amarantus Bioscience is a development-stage biotech company focused on the discovery and development of therapeutic proteins and biologics for the treatment of Parkinson’s disease, traumatic brain injury (TBI) and other human diseases. The company owns the intellectual property rights to Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF), which corrects protein misfolding. For further information, visit the company’s Web site at: www.amarantus.com

EBD Group’s Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event.

Let us hear your thoughts below: